DNA microarray analysis of rheumatoid arthritis susceptibility genes identified by genome-wide association studies by Sugino, Hidehiko et al.
In a recent interesting review, Alex Clarke and Timothy 
Vyse described the genetics of rheumatic disease [1]. In 
the past several years, genome-wide association studies 
(GWAS) have led to the identiﬁ  cation of six high-risk 
rheumatoid arthritis (RA) susceptibility genes – namely, 
CD244, PADI4, SLC22A2, PTPN22, CTLA4, and STAT4
(summarized in [2]). In vitro studies using mutant alleles 
and cultured cells have revealed the individual up-
regulation of CD244,  PADI4,  SLC22A2, and PTPN22
[2-6]; however, studies on the expression of RA 
susceptibility genes in RA patients are rare. We therefore 
investigated the expression of the above-mentioned six 
RA susceptibility genes in 112 RA patients using DNA 
microarray analysis. Th  is study aims to clarify whether 
DNA microarray analysis and GWAS produce com-
parable results with respect to RA susceptibility genes.
Total RNA extracted from total peripheral blood cells 
obtained from 112 RA patients and 45 healthy individuals 
was used to prepare aminoallyl RNA. As a reference, 
mixed RNA from 45 healthy individuals was used. Th  e 
aminoallyl RNA of each individual and the reference was 
subjected to Cy3 and Cy5 labeling, respectively, and was 
hybridized with an oligonucleotide-based DNA micro-
array. Th   e data obtained were analyzed by nonparametric 
statistical group comparison. Th  e intensities of the no-
probe spots were used as the background. Th  e median 
and standard deviation of the background intensity were 
calculated. Th   e genes with an intensity value that was less 
than the median plus 2 standard deviation of the 
background intensity were identiﬁ  ed as null. Th  e Cy3/
Cy5 ratios of all spots on the DNA micro  array were 
normalized using the global ratio median. Only gene 
expression data that were collected from at least 80% of 
samples from each group were selected for further 
analysis. Th   e unpaired Mann–Whitney test was used to 
determine statistically signiﬁ  cant  diﬀ   erences in the 
mRNA expression levels between the RA and healthy 
groups. Statistical signiﬁ  cance was set at P <0.05.
Th  e results of our DNA microarray analysis showed 
that the expressions of four out of the six RA suscep-
tibility genes were signiﬁ   cantly higher in RA patients 
than in healthy individuals (1.0 x 10–16 to 2.32 x 10–5) 
(Table 1). As described above, the upregulation of these 
four genes (CD244, PADI4, SLC22A2, and PTPN22) has 
been previously conﬁ  rmed in in vitro studies. We found, 
however, that CTLA4 expression levels were similar 
between the RA and control groups, whereas STAT4
expression was signiﬁ   cantly downregulated in the RA 
group (1.38 x 10–8). We investigated the expression of 
other RA susceptibility genes – namely, TRF1/C5 [7], 
CD40 [8], and CCL21 [8] – and found that their 
expressions were similar in both groups. Th  e  genetic  risk 
factors for RA were recently reported to diﬀ  er between 
Caucasian and Asian (Korean) populations [9]. Th  e 
samples used in our microarray analysis were derived 
from the same Asian (Japanese) cohort. Th  e expression 
proﬁ   les for these three genes may therefore not be 
consistent with the proﬁ  les determined by GWAS.
In this study, we revealed the correlation between ﬁ  ve 
out of the six high-risk RA susceptibility genes using 
DNA micro  array analysis. Prostate cancer susceptibility 
genes identiﬁ  ed by GWAS were recently reported  to be 
consistent with those identiﬁ  ed by microarray analysis 
[10]. We therefore con  cluded that the combination of 
microarray analysis and GWAS would be a more eﬀ  ective 
approach for gene identiﬁ   cation than the analysis of 
individual datasets. Moreover, the simultaneous use of 
both methods would allow for more accurate 
identiﬁ  cation of RA candidate genes. © 2010 BioMed Central Ltd
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Table 1. Candidate genes identifi  ed from rheumatoid arthritis genome-wide association studies
Gene  GeneID  PMID  Gene expression (up or down)  Microarray P valuesa
CD244  605554  18794858  Up  1.0 x 10–16
PADI4  605347  12833157  Up  2.32 x 10–5
SLC22A2  602608  14608356  Up  1.94 x 10–6
PTPN22  600716  15208781  Up  9.66 x 10–8
CTLA4  123890  16380915   No change  0.767
STAT4  600558  17804842  Up  1.38 x 10–8
aP values determined by comparison between 112 rheumatoid arthritis patients and 45 healthy individuals.
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